Aims and scope
ExRNA is a peer-reviewed, open access journal that provides a platform for innovative research in the field of extracellular RNA. The journal covers a wide variety of RNAs in the extracellular environment, including miRNAs, siRNAs, piRNAs, lncRNAs and circRNAs.
This journal aims to investigate the biological functions of extracellular RNAs, discover the fundamental principles about the mechanisms of extracellular RNA generation, uptake and transport and explore the potential for using extracellular RNAs in the clinic as therapeutic molecules or disease biomarkers.
ExRNA encompasses all topics related to the biology of extracellular RNAs, including, but not limited to:
- Functional analysis of the biodistribution, structure and biological activity of extracellular RNAs
- Mechanistic studies on the production, transport, uptake, processing, modulation and modification of extracellular RNAs
- Translational studies to identify biomarkers and develop new tools, therapies and technologies to measure extracellular RNAs.
All articles published by ExRNA are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in ExRNA you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
The publication costs for ExRNA are covered by Nanjing University, so authors do not need to pay an article-processing charge.
ExRNA operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Publication of research articles by ExRNA is dependent primarily on their scientific validity and coherence as judged by our external expert editors and/or peer reviewers, who will also assess whether the writing is comprehensible and whether the work represents a useful contribution to the field.
All manuscripts submitted to ExRNA should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in ExRNA
ExRNA's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
ExRNA offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in ExRNA gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in ExRNA are included in article alerts and regular email updates. Some may be highlighted on ExRNA’s pages and on the BioMed Central homepage.
In addition, articles published in ExRNA may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in ExRNA. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in ExRNA you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.